✦ LIBER ✦

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

✍ Scribed by Han, J.-Y.; Park, K.; Kim, S.-W.; Lee, D. H.; Kim, H. Y.; Kim, H. T.; Ahn, M. J.; Yun, T.; Ahn, J. S.; Suh, C.; Lee, J.-S.; Yoon, S. J.; Han, J. H.; Lee, J. W.; Jo, S. J.; Lee, J. S.

Book ID: 121346181
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 156 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2011.36.8456

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An International, Multicenter, Randomize

An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial

✍ Cesare Gridelli; Charles Butts; Fortunato Ciardiello; Ronald Feld; Ciro Gallo; F 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 91 KB

3502 ORAL Final results of a randomized

3502 ORAL Final results of a randomized phase III trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP)

✍ S.E. Al-Batran; J.T. Hartmann; S. Probst; R. Hofheinz; J. Stoehlmacher; C. Pauli 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 76 KB

O-91 First line treatment with gemcitabi

O-91 First line treatment with gemcitabine (G) and vinorelbine (V) versus cisplatin (C) gemcitabine and vinorelbine (CGV) in advanced non small cell lung cancer (NSCLC). Preliminary results of a randomised study of the GON (Grupo Oncológico del Norte de Espan˜a)

✍ Esteban, Emilio; Fra, Joaquin; Vietez, Jose María; Palacio, Isabel; De Sande, Jo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 331 KB

P-554 Randomized Phase II study of first

P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group

✍ Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB